• Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

I7G:GR

37.700 EUR 0.240 0.63%

As of 08:00:51 ET on 09/15/2014.

Snapshot for Ipsen SA (I7G)

Open: 37.850 Day's Range: 37.682 - 37.940 Volume: 100
Previous Close: 37.940 52wk Range: 26.200 - 38.470 1-Yr Rtn: +46.87%

Stock Chart for I7G

No chart data available.
  • I7G:GR 37.700
  • 1D
  • 1M
  • 1Y
37.940
Interactive I7G Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for I7G

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 18.1512
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 2.0770
Est. PEG Ratio 1.6286
Market Cap (M EUR) 3,120.85
Shares Outstanding (M) 82.78
30 Day Average Volume 18
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.12%
Cash Dividend (EUR) 0.8000
Dividend Ex-Date 06/09/2014
5 Year Dividend Growth 2.71%
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for I7G

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for I7G

Ipsen SA manufactures and markets a wide range of medical drugs for targeted disease areas including oncology, endocrinology, and neuromuscular disorders.

Marc De GaridelChairman/CEOChristel BoriesDeputy CEO
Susheel SurpalExec VP/CFONathalie JoannesExec VP/General Counsel
More Company Profile & Key Executives for I7G

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil